These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 34826399

  • 1. Hypoxia inducible factor-3α promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9.
    Li ZF, Meng DD, Liu YY, Bi FG, Tian K, Xu JZ, Sun JG, Gu CX, Li Y.
    Chem Biol Interact; 2022 Jan 05; 351():109759. PubMed ID: 34826399
    [Abstract] [Full Text] [Related]

  • 2. KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development.
    Wang W, Wang B.
    BMC Cancer; 2022 May 19; 22(1):562. PubMed ID: 35590288
    [Abstract] [Full Text] [Related]

  • 3. Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α.
    Guo X, Tian Z, Wang X, Pan S, Huang W, Shen Y, Gui Y, Duan X, Cai Z.
    Acta Biochim Biophys Sin (Shanghai); 2015 Feb 19; 47(2):106-13. PubMed ID: 25520177
    [Abstract] [Full Text] [Related]

  • 4. KDM3A promotes oral squamous cell carcinoma cell proliferation and invasion via H3K9me2 demethylation-activated DCLK1.
    Yang L, Zhang Q, Yang Q.
    Genes Genomics; 2022 Nov 19; 44(11):1333-1342. PubMed ID: 36094735
    [Abstract] [Full Text] [Related]

  • 5. The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice.
    Dandawate P, Ghosh C, Palaniyandi K, Paul S, Rawal S, Pradhan R, Sayed AAA, Choudhury S, Standing D, Subramaniam D, Padhye SB, Gunewardena S, Thomas SM, Neil MO, Tawfik O, Welch DR, Jensen RA, Maliski S, Weir S, Iwakuma T, Anant S, Dhar A.
    Gastroenterology; 2019 Dec 19; 157(6):1646-1659.e11. PubMed ID: 31442435
    [Abstract] [Full Text] [Related]

  • 6. Lysine demethylase 3A in hypoxic macrophages promotes ovarian cancer development through regulation of the vascular endothelial growth factor A/Akt signaling.
    Song Y, Li L, Xi Y.
    Tissue Cell; 2023 Dec 19; 85():102253. PubMed ID: 37890327
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-449a delays lung cancer development through inhibiting KDM3A/HIF-1α axis.
    Hu S, Cao P, Kong K, Han P, Deng Y, Li F, Zhao B.
    J Transl Med; 2021 May 27; 19(1):224. PubMed ID: 34044859
    [Abstract] [Full Text] [Related]

  • 8. KDM3A histone demethylase functions as an essential factor for activation of JAK2-STAT3 signaling pathway.
    Kim H, Kim D, Choi SA, Kim CR, Oh SK, Pyo KE, Kim J, Lee SH, Yoon JB, Zhang Y, Baek SH.
    Proc Natl Acad Sci U S A; 2018 Nov 13; 115(46):11766-11771. PubMed ID: 30377265
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. HIF-KDM3A-MMP12 regulatory circuit ensures trophoblast plasticity and placental adaptations to hypoxia.
    Chakraborty D, Cui W, Rosario GX, Scott RL, Dhakal P, Renaud SJ, Tachibana M, Rumi MA, Mason CW, Krieg AJ, Soares MJ.
    Proc Natl Acad Sci U S A; 2016 Nov 15; 113(46):E7212-E7221. PubMed ID: 27807143
    [Abstract] [Full Text] [Related]

  • 11. Metabolism of Reactive Oxygen Species in Osteosarcoma and Potential Treatment Applications.
    Sun W, Wang B, Qu XL, Zheng BQ, Huang WD, Sun ZW, Wang CM, Chen Y.
    Cells; 2019 Dec 30; 9(1):. PubMed ID: 31905813
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.
    Chen J, Zhang J, Yang J, Xu L, Hu Q, Xu C, Yang S, Jiang H.
    Atherosclerosis; 2017 Feb 30; 257():152-163. PubMed ID: 28135625
    [Abstract] [Full Text] [Related]

  • 15. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H, Zhao L.
    J Cell Biochem; 2019 Apr 30; 120(4):6502-6514. PubMed ID: 30485482
    [Abstract] [Full Text] [Related]

  • 16. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
    Zhang B, Li YL, Zhao JL, Zhen O, Yu C, Yang BH, Yu XR.
    Biomed Pharmacother; 2018 Sep 30; 105():1-9. PubMed ID: 29807229
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.
    Jiang Y, Li F, Gao B, Ma M, Chen M, Wu Y, Zhang W, Sun Y, Liu S, Shen H.
    Theranostics; 2021 Sep 30; 11(8):3868-3881. PubMed ID: 33664867
    [Abstract] [Full Text] [Related]

  • 19. KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis.
    Qian X, Li X, Shi Z, Bai X, Xia Y, Zheng Y, Xu D, Chen F, You Y, Fang J, Hu Z, Zhou Q, Lu Z.
    Mol Cell; 2019 Dec 19; 76(6):885-895.e7. PubMed ID: 31629659
    [Abstract] [Full Text] [Related]

  • 20. HIF-1α/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury.
    Zhao M, Wang S, Zuo A, Zhang J, Wen W, Jiang W, Chen H, Liang D, Sun J, Wang M.
    Cell Mol Biol Lett; 2021 Sep 03; 26(1):40. PubMed ID: 34479471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.